Multidisciplinary Approaches to Tumor Immunology
Multidisciplinary Approaches to Tumor Immunology
批准号:
10248383
负责人:
Scott I. Abrams
金额:
$13.55万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The overarching goals of the Tumor Immunology Training Program (TITP) at the Roswell Park Cancer Institute
(RPCI) Graduate Division are to educate, train and prepare talented pre-doctoral students for a profession in
cancer immunology research. Driven by significant advances in understanding how the immune system can
be weaponized against cancer, future leaders in tumor immunology will not only be well-trained in the
discipline, but also will have a strong appreciation of the potential translational impact to human cancer biology
and therapy. The unique, cancer-focus within the TITP introduces trainees to an advanced didactic and
conceptual cancer immunology educational paradigm that encapsulates knowledge spanning the continuum of
basic science to clinical application. The uniqueness of this TITP is further enhanced by the integration of an
academic environment comprised of diverse faculty concentrated within a prestigious NCI-designated
Comprehensive Cancer Center. Trainees are exposed to a comprehensive portfolio of cancer-related topics
that will be enhanced through a new “umbrella” academic curriculum starting in the fall of 2018. It is during the
first year of study when trainees will select the tumor immunology-specific “track” and then conduct their
doctoral research with TITP faculty with expertise in basic, translational, or clinical sciences. The primary
mission of the training grant renewal is to support competitively selected students during their third and fourth
years of study. The funds requested cover stipends and tuition for 4 pre-doctoral students per year. This
funding is crucial to continue the upward trajectory experienced for nearly 15 years of NRSA support in the
quality and diversity of pre-doctoral trainees focused on complex and challenging immunologic questions in
cancer. NRSA-supported trainees are prepared for a competitive biomedical career through didactic lectures
and concept-driven learning in tumor immunology and biology, grant writing and ethical conduct of research.
After completing all formal course work, degree conferral is dependent upon passing the preliminary exam,
fulfilling a first-authored publication requirement, and passing the dissertation defense reflecting the novel and
original findings of the student's body-of-work. Trainees who complete this TITP will be well-versed in all major
facets of tumor immunology and will have the solid foundation upon which to build cancer-focused careers,
guided by a clear vision of its impact on human cancer biology and treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
-
批准号:10322156
-
项目类别:
-
资助金额:$69.42万
-
财政年份:2021
-
负责人:Scott I. Abrams
-
依托单位:
Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer
-
批准号:10463811
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2021
-
负责人:Scott I. Abrams
-
依托单位:
Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer
-
批准号:10287834
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2021
-
负责人:Scott I. Abrams
-
依托单位:
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
-
批准号:10543820
-
项目类别:
-
资助金额:$68.03万
-
财政年份:2021
-
负责人:Scott I. Abrams
-
依托单位:
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
-
批准号:10653186
-
项目类别:
-
资助金额:$111.27万
-
财政年份:2020
-
负责人:Scott I. Abrams
-
依托单位:
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
-
批准号:10171569
-
项目类别:
-
资助金额:$95.12万
-
财政年份:2020
-
负责人:Scott I. Abrams
-
依托单位:
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
-
批准号:10404988
-
项目类别:
-
资助金额:$99.3万
-
财政年份:2020
-
负责人:Scott I. Abrams
-
依托单位:
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
-
批准号:10320831
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2020
-
负责人:Scott I. Abrams
-
依托单位:
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
-
批准号:10557071
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2020
-
负责人:Scott I. Abrams
-
依托单位:
Multidisciplinary Approaches to Tumor Immunology
-
批准号:10472619
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2019
-
负责人:Scott I. Abrams
-
依托单位:
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
-
批准号:9017958
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2015
-
负责人:Scott I. Abrams
-
依托单位:
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
-
批准号:9207748
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2015
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:8841514
-
项目类别:
-
资助金额:$1.76万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:8322028
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:8105762
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:9088540
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:8745184
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:8701873
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
-
批准号:8515751
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2011
-
负责人:Scott I. Abrams
-
依托单位:
Multidisciplinary Approaches to Tumor Immunology
-
批准号:10709095
-
项目类别:
-
资助金额:$14.41万
-
财政年份:2001
-
负责人:Scott I. Abrams
-
依托单位:
海外基金